Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Advanced Breast Cancer × Sirolimus × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Waldenstrom Macroglobulinemia 1 Skin Neoplasms 1 Pseudomyxoma Peritonei 1 Neoplasms, Plasma Cell 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Breast Neoplasms 1 Advanced Breast Cancer 1 Adenomatous Polyposis Coli 1

Interventions

palbociclib 1 dalpiciclib 1 Sirolimus 1 Fulvestrant 1 Docetaxel 1 AZD9833 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06941142 2025-04-23

A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Not yet recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡